Encompass Health revenue and financials
$122.63Change from previous close: −1.65%Absolute change: −$2.06
In the fiscal year ended December 2025, Encompass Health reported revenue of $5.94B (+10.46% year over year). Net income was $566.2M, a net margin of 9.5%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.46%
- 2025 vs 2024
- Net income growth
- +24.25%
- 2025 vs 2024
- Net margin
- 9.5%
- 2024: 8.5%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 1,176 | 1,003 | 851 | 706 | 716 |
| Depreciation and amortization | 328 | 300 | 274 | 244 | 220 |
| Capital expenditure | -736 | -643 | -583 | -584 | -546 |
| Investing cash flow | -765 | -653 | -603 | -627 | -666 |
| Financing cash flow | -431 | -331 | -197 | -146 | -240 |
| Dividends paid | -71.1 | -62.8 | -60.4 | -99.0 | -112 |
| Share repurchases | -178 | -43.2 | -8.2 | -7.3 | -14.6 |
| Debt issued | 210 | 95.0 | 80.0 | 252 | — |
| Debt repaid | -239 | -337 | -163 | -750 | — |
| Net change in cash | -20.2 | 18.9 | 50.8 | -66.9 | -191 |
| Free cash flow | 439 | 360 | 268 | 122 | 170 |
| Levered free cash flow | 297 | 216 | 124 | -3.3 | -73.9 |
